Item 8.01  Other Events

Second Sight Medical Products, Inc. (the "Company") was notified on July 14, 2022, that the National Institutes of Health ("NIH") released year four funding in the amount of $1.1 million of the $6.4 million planned five-year grant, 5UH3NS103442. The Company uses the funds primarily to pay UCLA and Baylor College of Medicine to conduct the Early Feasibility Clinical Trial of a Visual Cortical Prosthesis. The Company issued a press release entitled Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study, which is attached to this Current Report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit
No.        Description
  99.1       Second Sight Medical Products Announces Year Four NIH Funding of its
           Orion Study dated July 18, 2022.
104        The cover page of this Current Report on Form 8-K, formatted in Inline
           XBRL.

© Edgar Online, source Glimpses